Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AbbVie AndroGel Jury Verdict Targets 'Low T' Promotion

Jul 25 2017

• By Brenda Sandburg

TestosteroneBlood Test_1200x675

Related Content

‘Low-T’ Drugs Need Randomized CV Safety Trials, FDA Panel Says

Sep 18 2014

Product Liability Suits: Testosterone, Lipitor Grow While Yaz, Pradaxa Settle

Jan 19 2015

Related Companies

AbbVie Inc.

Allergan plc

Endo, Inc.

Eli Lilly and Company

Pfizer Inc.

Additional Topics

Policy Legal Issues Drug Safety BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.